Geraldine M. Camilleri - Publications

Dihydropyrimidine dehydrogenase phenotype-guided dose individualization of fluoropyrimidine in gastrointestinal cancers: PRODIGE100-UCGI48-FUDOSE phase II study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 18, 2026

Integrating tumor volumetry and liquid biopsy: a New model to define prognosis in advanced pancreatic ductal adenocarcinoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 01, 2026

Anti-Epidermal Growth Factor Receptor Therapy in EGFR-Amplified Esophagogastric Cancers: An Underestimated Efficacy.

Journal: JCO precision oncology

Published: December 10, 2025

The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma.

Journal: Cancers

Published: November 12, 2025

Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 11, 2025

Targeting the liver: Insights from a tertiary center on post-operative hepatic arterial oxaliplatin for metastatic colorectal cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 04, 2025